AU2024201641B2 — Methods of treating hfpef employing dapagliflozin and compositions comprising the same

USPTO Abstract

#$%^&*AU2024201641B220250911.pdf##### ABSTRACT OF THE DISCLOSURE Methods for treating and/or preventing HFpEF and/or at least one disease, disorder, and/or condition associated therewith in patients by the use of dapagliflozin and compositions comprising the same are disclosed. ABSTRACT OF THE DISCLOSURE Methods for treating and/or preventing HFpEF and/or at least one disease, disorder, and/or condition associated therewith in patients by the use of dapagliflozin and compositions comprising the same are disclosed. 20 24 20 16 41 13 M ar 2 02 4 A B S T R A C T O F T H E D I S C L O S U R E M e t h o d s f o r t r e a t i n g a n d / o r p r e v e n t i n g H F p E F a n d / o r a t l e a s t o n e d i s e a s e , d i s o r d e r , 2 0 2 4 2 0 1 6 4 1 1 3 M a r 2 0 2 4 a n d / o r c o n d i t i o n a s s o c i a t e d t h e r e w i t h i n p a t i e n t s b y t h e u s e o f d a p a g l i f l o z i n a n d c o m p o s i t i o n s c o m p r i s i n g t h e s a m e a r e d i s c l o s e d .